Antiplatelet and Anticoagulation Therapies

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, international normalized ratio (INR) testing, oral anticoagulants, IV administered drugs such as Heprin, and dual antiplatelet therapy (DAPT). The most commonly used anticoagulant is warfarin, which available in generic form at a low cost. However, it has a narrow therapeutic window and its effectiveness is altered by food containing vitamin K. To regulate warfarin, regular INR testing is needed. The newer anticoagulation drugs are referred to as novel oral anticoagulant (NOAC). However, since some of these drugs are now more than six years old, they are commonly referred to as non-vitamin K oral anticoagulant (NOAC), and the newest term, direct oral anticoagulant (DOAC). NOAC or DOAC agents have much larger therapeutic windows, do not require INR testing. Aspirin and clopidogrel (Plavix) are the most commonly used antiplatelet agents for the prevention of heart attacks and stroke. They are often prescribed together as DAPT.

News | September 05, 2013
September 5, 2013 — ITC Nexus Holding Co., a company in hemostasis management and point-of-care (POC) testing,...
News | August 05, 2013
August 5, 2013 — AstraZeneca announced results from a new sub-analysis of the PLATO study that evaluated the incidence...
News | July 25, 2013
July 25, 2013 — Merck announced that the New Drug Application (NDA) for its investigational anti-thrombotic medicine,...
News | July 22, 2013
July 22, 2013 — T2 Biosystems announced the presentation of data strongly correlating T2Hemostat results with patients...
News | July 15, 2013
July 15, 2013 — Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) has issued...
Clinical Study Aspirin Duke Medicine Blood Test Platelet Functioning Testing
News | July 12, 2013
July 12, 2013 — Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients...
cath lab, SYNTAX, SCAI
Feature | July 03, 2013 | Dmitriy N. Feldman, M.D., FACC, FSCAI
The year 2013 has brought us several important clinical trials that have changed the way interventional cardiologists...
University of Maryland Medical Center Genetic-Testing Program Cardiac Stent
Feature | May 17, 2013
May 17, 2013 — Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center...
Technology | April 30, 2013
April 30, 2013 — The U.S. Food and Drug Administration (FDA) approved Kcentra (prothrombin complex concentrate, human)...
UK Blood Clots Teststing Wafarin Self Monitoring
News | April 29, 2013
April 29, 2013 — A simple self-monitoring test could reduce the risk of stroke by half in thousands of people in the...
Accumetrics Inc. VerifyNow P2Y12 Test Bleeding Ischemic Events
News | April 16, 2013
April 16, 2013 — Accumetrics Inc. announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test....
News | April 12, 2013
April 12, 2013 — The U.S. Food and Drug Administration (FDA) issued a second complete response letter regarding a...
Technology | April 05, 2013
April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner...
AspirinWorks Test Kit
Technology | April 04, 2013
April 4, 2013 — Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test ...
CHAMPION PHOENIX clinical study anti-platelet therapy cangrelor ACC 13
Feature | April 04, 2013
April 4, 2013 — The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large...